Photo of Maria Cantwell
D United States Senate · Washington

Sen. Maria Cantwell

Compare
Total votes
1,037
all sessions
Attendance
99%
7 missed
Higher than 86% of chamber peers
With party
98%
of cast votes
Near the chamber average
Bipartisan score
1%
crosses aisle rarely
Near the chamber average
Sponsored
787
bills & resolutions
Lower than 81% of chamber peers
Committees
13
assignments
787 bills and resolutions

Sponsored bills

Total
787
Primary
93
Co-sponsor
694
This page
787
matching current filters
Co-sponsor S 4355
In committee · Delaware Senate · Co-sponsor
Drug Deal Disclosure Act

Maddy summaryThe Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release specific records regarding agreements between the federal government and major drug manufacturers starting in 2025. This law mandates the disclosure of contracts that include provisions such as reduced drug prices based on international rates, direct-to-consumer sales discounts, duty exemptions, and special treatment for Medicare programs. While the bill allows for the redaction of confidential pricing details, it prohibits withholding information based on political sensitivity or reputational harm and requires a detailed justification for any redactions. Additionally, the act mandates reports to Congress and independent analysis from the Congressional Budget Office and the Government Accountability Office to evaluate the economic and budgetary impacts of these agreements.

In committee Apr 21, 2026 1 co-sponsor
Co-sponsor S 4351
In committee · Delaware Senate · Co-sponsor
Energy Consumer Protection Act of 2026

Energy Consumer Protection Act of 2026 This bill expands enforcement provisions under the Federal Power Act and the Natural Gas Act to protect consumers from price manipulation, including by allowing the Federal Energy Regulatory Commission to temporarily or permanently ban any person from trading in energy markets if the person (1) violates those acts by manipulating the electricity or natural gas markets, or (2) files false information regarding those markets.

In committee Apr 21, 2026 1 co-sponsor
Co-sponsor SRES 679
Passed · Delaware Senate · Co-sponsor
A resolution recognizing April 14, 2026, as "World Quantum Day", and commemorating and supporting the goals of World Quantum Day.

Maddy summaryThis Senate Resolution recognizes April 14, 2026, as "World Quantum Day." It supports the day's goals of celebrating the role of quantum physics in daily life and encourages schools and educators to observe it with activities that teach students about quantum physics and engage them in STEM fields.

Passed Apr 16, 2026 1 co-sponsor
Co-sponsor S 4318
In committee · Delaware Senate · Co-sponsor
Breast Cancer Stamp Reauthorization Act

Maddy summaryThe Breast Cancer Stamp Reauthorization Act extends the sale of a special postage stamp dedicated to breast cancer research until the year 2037. This change directly affects the United States Postal Service and the public by allowing the continued availability of this specific stamp for purchase. The bill achieves this by amending federal law to update the expiration date for the stamp's authorized sale period. No other policy changes or funding mechanisms are introduced by this legislation.

In committee Apr 16, 2026 1 co-sponsor
Primary S 4311
In committee · Delaware Senate · Lead sponsor
Consumer Protection Remedies Act of 2026

Maddy summaryThe Consumer Protection Remedies Act of 2026 amends the Federal Trade Commission Act to expand the Commission's legal tools for addressing consumer violations. It allows the FTC to seek court orders for returning money to harmed consumers, canceling or fixing unfair contracts, and requiring companies to give up illegal profits gained from violations. These new remedies are limited to actions taken within the last 10 years, and time spent by the accused party outside the United States does not count toward this deadline. The changes apply to any legal case started on or after the bill becomes law.

In committee Apr 15, 2026 0 co-sponsors
Co-sponsor S 4310
In committee · Delaware Senate · Co-sponsor
No Tax on Overtime for All Workers Act

Maddy summaryThe No Tax on Overtime for All Workers Act aims to exclude specific types of overtime pay from federal income taxation. It directly affects workers who receive compensation for hours worked beyond a standard 40-hour week under certain collective bargaining agreements. The bill defines this tax-free overtime as pay exceeding the regular rate for work that is either required by the Fair Labor Standards Act or agreed upon in advance for periods of at least 40 hours per week. Additionally, it includes special provisions for employees covered by the Railway Labor Act, allowing tax-free treatment for overtime beyond scheduled or maximum duty hours as defined by their agreements. These tax benefits would apply to taxable years beginning after December 31, 2024.

In committee Apr 15, 2026 1 co-sponsor
Co-sponsor S 545
In committee · Delaware Senate · Co-sponsor
Combating Illicit Xylazine Act

Maddy summaryThe Combating Illicit Xylazine Act places xylazine - a veterinary sedative increasingly found in illicit drug mixtures - into Schedule III of the Controlled Substances Act, subjecting it to federal regulation as a controlled substance. It specifically allows veterinary use without requiring registration of the ultimate user (e.g., pet owners or veterinarians) if xylazine is dispensed by a registered veterinarian or pharmacy with a vet prescription and used for animals owned by the user, under their care, or in authorized animal programs. The bill provides a one-year delay for labeling and packaging requirements and a 60-day delay for registration and recordkeeping for veterinary use to ease implementation. Additionally, it adds xylazine to the Arcos tracking system for controlled substances and mandates two congressional reports on illicit use prevalence within 18 months and 4 years of enactment.

In committee Apr 15, 2026 1 co-sponsor
Co-sponsor S 3791
In committee · Delaware Senate · Co-sponsor
Regional Ocean Partnerships Reauthorization Act of 2026

Maddy summaryThis bill reauthorizes existing regional ocean partnerships through 2031, extending funding for coastal states and tribes managing ocean resources. It sets specific annual funding levels: $11.57 million for 2028, $11.69 million for 2029, $11.81 million for 2030, and $11.92 million for 2031. The bill makes technical updates to reporting requirements and adjusts the funding period to align with the new authorization. It directly affects current regional ocean partnership programs under the 2023 defense act, ensuring continued federal support for coastal management efforts.

In committee Apr 14, 2026 1 co-sponsor
Co-sponsor S 3597
In committee · Delaware Senate · Co-sponsor
National Quantum Initiative Reauthorization Act of 2026

Maddy summaryThe National Quantum Initiative Reauthorization Act of 2026 reauthorizes and expands federal efforts to advance quantum information science, engineering, and technology through 2034. The bill establishes new workforce development programs, including quantum education initiatives, traineeships, and a Quantum Reskilling, Education, and Workforce Coordination Hub to address talent needs. It creates an International Quantum Cooperation Strategy to foster partnerships with allies and addresses quantum supply chain vulnerabilities through mapping and planning efforts. The act includes specific funding allocations for quantum research centers, testbeds, and post-quantum cryptography development, with annual evaluations required to assess program effectiveness. The legislation directly affects federal agencies, research institutions, and the quantum industry by providing structured funding and coordination for quantum technology advancement.

In committee Apr 14, 2026 1 co-sponsor
Showing 51 to 60 of 787 bills
Previous 1 5 6 7 79 Next